ABOUT US

 

Over the past couple of decades, the exponential progress of sequencing technologies has allowed an increasing number of cancer patients to benefit from precision oncology. However, the aggregation, analysis, and visualization of the massive amounts of genomic data remain a major challenge for precision oncology expansion.

The Epigene Labs technology platform enables cancer drug hunters to seamlessly leverage advanced artificial intelligence in transforming genomic data into actionable insights for designing precision oncology approaches.

With R&D in Paris and business development in Boston, Epigene Labs operates in the setting of value-based partnerships with world leading cancer centers and high-profile biotechs.

PRECISION ONCOLOGY CYCLE

 

PLATFORM

 
 

OUR TEAM

We are humble. We are bold.

 
Akpéli Nordor, PharmD, PhD

Co-founder & President

Paris

Arthur de Garidel, JD, MSc

Co-founder

Boston

Julien Haziza, PharmD, MSc

Data Scientist

Paris

 
 

SUPPORTERS

They trust us

  • Harvard Innovation Labs

  • Cancer Campus

  • INSEAD ECA
 
 

GET IN TOUCH

 

Interested in partnering or working with us? Drop us a line!